Could inducing labor at 39 weeks cut C-Sections? new chinese trial aims to find out
NCT ID NCT07082530
First seen Jun 25, 2026 · Last updated Jul 31, 2026 · Updated 3 times
Summary
This study is testing whether inducing labor at 39 weeks in low-risk pregnant women reduces the need for C-sections compared to waiting for labor to start naturally or inducing at 41 weeks. Over 1,000 women in China are taking part. The researchers will also analyze cord blood to look for markers that might predict long-term child health.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could provide evidence to support earlier labor induction in low-risk pregnancies, potentially reducing C-section rates and improving outcomes for mothers and babies in China.
- What could go wrong
- This is a single-country trial, so results may not apply elsewhere. The study is still recruiting, and the benefits seen in other populations may not hold true for Chinese women.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 1,074 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jul 2025
- Expected to finish
-
Jun 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Female participants only
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Age ≥18 years. 2. Singleton pregnancy or twin pregnancy reduced to singleton before 14 weeks. 3. Gestational age between 38 weeks 4 days or 38 weeks 6 days at randomization. 4. Eligible for vaginal delivery with a desire for vaginal birth. 5. Reliable gestational age determination. 6. Maternal and fetal conditions assessed as low-risk by at least two senior obstetricians, with no indications requiring delivery before 41 weeks. 7. Ability to understand study information and provide informed consent. Exclusion Criteria: 1. First-trimester ultrasound estimate \>13 weeks 6 days. 2. Planned induction before 41 weeks. 3. Planned cesarean delivery or contraindications to vaginal delivery. 4. Already delivered, in labor, or ruptured membranes at enrollment. 5. Placenta previa, vasa previa, placenta accreta, or placental abruption. 6. Contraindications to induction (e.g., cervical cancer, history of uterine rupture, genital tract malformations, abnormal fetal position, cord prolapse). 7. Active vaginal bleeding exceeding spotting. 8. History of cesarean delivery or uterine/cervical surgery. 9. Cervical cerclage during this pregnancy. 10. Maternal conditions not suitable for expectant management beyond 39 weeks (e.g., pregestational diabetes, gestational diabetes requiring insulin, hypertensive disorders, intrahepatic cholestasis of pregnancy). 11. Fetal conditions not suitable for expectant management beyond 39 weeks (e.g., fetal death, major anomalies, growth restriction, macrosomia, anemia, oligohydramnios, polyhydramnios). 12. Maternal infections or positive screenings for sexually transmitted pathogens or group B Streptococcus. 13. Planned delivery at a non-study facility. 14. Participation in another intervention study affecting delivery management.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cesarean delivery are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Women's Hospital School of Medicine Zhejiang University
RECRUITINGHangzhou, Zhejiang, 310006, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new pain drug match morphine for C-Section recovery?
- Could a simple wrist grip ease anxiety during C-Section?
- Could a scent and a touch soothe Post-Surgery pain?
- Finger sensor may read pain and anxiety during c-section
- Eye reflex may flag hidden risk in cesarean births
- Could adding oxytocin speed up labor induction after a C-Section?